such as irradiation and oxidative stress. 1, 5 Furthermore, recent studies have demonstrated that treatment with chemotherapeutic drugs or ionizing radiation provokes "therapy-induced senescence (TIS)" in tumor cells. 6, 7 Persistent DNA damage response causes cellular senescence in normal cells, 8, 9 and induces expression of the cyclin-dependent kinase (CDK) inhibitors p16 INK4a and p21 WAF1/CIP1 . p16 INK4a inhibits the cyclin D-CDK4/6 complex, 10 whereas p21 WAF1/CIP1 blocks cyclin E-CDK2 activity. 11 Both checkpoint proteins block retinoblastoma protein, thereby suppressing expression of E2F target genes and inducing senescent cell cycle arrest ( Figure 1 ). [12] [13] [14] Generally, cellular senescence is a state of essentially irreversible cell cycle arrest; however, several studies have reported that a small population of senescent cells can override the senescent cell cycle arrest and re-enter the cell cycle under some particular conditions. 15, 16 Recently, the selective CDK4/6 inhibitors abemaciclib, palbociclib and ribociclib have been shown to induce senescence-like cell cycle arrest in some cancer cell lines. These effects led to their approval for estrogen receptor-positive breast cancer treatment. 17, 18 Senescent cells show some typical morphological features, such as a flattened shape and vacuolization. 19 As persistent DNA damage signals are critical for induction of cellular senescence, it has been suggested that DNA damage foci could be used to identify senescent cells. Potential targets include accumulation of 53BP1, phosphorylation of histone H2A.X, or other DNA repair markers. 20 In addition, chromatin reorganization occurs in senescent cells, termed senescence-associated heterochromatin foci (SAHF), which colocalize with trimethylated histone H3 lysine 9 (H3K9me3) and heterochromatin protein 1 and suppress the transcription of proliferation-related genes. 21 Moreover, downregulation of the nuclear lamina protein Lamin B1 also serves as a marker for senescent cells. 22 Of these, senescence-associated β-galactosidase (SA-β-gal)
staining is the most common and popular marker for identification of senescent cells. 23 SA-β-gal activity is based on upregulation of the lysosomal β-galactosidase gene (GLB1) and is detectable at pH 6. 24 However, SA-β-gal activity is not specific for senescent cells.
14 Therefore, a combination of several markers is needed to identify senescent cells. [32] [33] [34] There is a myriad of physiological activity associated with SASP factors (Figure 2 ). At first, SASP factors secreted from senescent cells were regarded as paracrine and autocrine enhancers of tumor suppressive effects in cellular senescence to prevent the growth of damaged cells. [33] [34] [35] In addition to this function, SASP Furthermore, it has been reported that some SASP factors can promote tissue repairing under a variety of conditions. Demaria et al 37 demonstrated that platelet-derived factor-AA (PDGF-AA) was secreted from senescent skin fibroblasts in the vicinity of damaged tissues to promote optimal wound healing. In response to liver injury, hepatic stellate cells (HSC) began to proliferate and produce extracellular matrixes for tissue repair before undergoing cellular senescence to prevent fibrosis. 38, 39 Moreover, these senescent HSC secreted growth factors, thereby promoting cell proliferation for tissue regeneration. In addition to tissue repair, SASP factors are involved in embryonic development of the apical ectodermal ridge and neural roof plate. 40, 41 In contrast to the beneficial effects of SASP in the living body, long-term survival of senescent cells also drives age-related diseases, such as atherosclerosis, neuropsychiatric disorders, chronic nephritis and cancer. 42 During the aging process, declining immune function leads to failures in senescence surveillance, resulting in accumulation of senescent cells. 43 Therefore, prolonged secretion of SASP factors, such as interleukin (IL)-1β and MMP, could drive cancer development. [44] [45] [46] Intriguingly, it has been reported that upregulation of IL-8 in senescent carcinoma-associated fibroblasts promotes invasion and metastasis of pancreatic cancer cells. 47 Our previous studies have established that IL-1β secreted from senescent HSC
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The biological function of senescence-associated secretory phenotype (SASP) factors in physiological and pathological conditions. SASP factors play important roles in common physiological conditions, as shown by the red arrows, such as wound healing (PDGF-AA, platelet-derived growth factor-AA), embryonic development (TGF-β, transforming growth factor-β; Wnt) and immune recruitment (CXCL1, CCL2 and CCL5). However, SASP factors also induce tumor progression and migration (MMP; IL-1β, interleukin-1β; VEGF, vascular endothelial growth factor) and suppression of anti-tumor immunity (PGE 2 , prostaglandin E2) under pathological conditions, as shown by the blue arrows. Moreover, SASP factors induce and maintain senescence cell cycle arrest through paracrine and autocrine factors in the liver plays an essential role in promoting obesity-associated hepatocellular carcinoma (HCC) in the obese mice model. Increased levels of deoxycholic acid (DCA), a gut bacterial metabolite derived from altered gut microbiota in obesity, induced cellular senescence and production of SASP factors in HSC, thereby promoting development of obesity-associated HCC. 45 Moreover, it was found that expression of COX-2, a rate-limiting enzyme involved in prostaglandin biosynthesis, significantly increased in senescent HSC. COX-2 induces overproduction of prostaglandin E 2 (PGE 2 ), resulting in suppression of anti-tumor immunity and progression of obesity-associated HCC. 48 Remarkably, cellular senescence has beneficial and harmful effects on cancer development via SASP.
| MOLECUL AR MECHANIS M OF S ENE SCEN CE-A SSO CIATED S ECRE TORY PHENOT YPE INDUC TION
According to previous reports, numerous mechanisms have been damage. [52] [53] [54] [55] In addition, the nutrient sensing pathways, mTOR and NAD, are involved in SASP regulation. [56] [57] [58] Recently, it has become apparent that toll-like receptors (TLR), an innate immune receptor, can trigger SASP induction. 48, 59, 60 TLR are pattern-recognition receptors that can recognize microbe-specific molecular signatures, known as pathogen-associated molecular patterns (PAMP) and self-derived molecules from damaged cells, known as damage-associated molecules patterns (DAMP). 61 A recent study by Hari et al indicated that the acute-phase serum amyloids A1 and A2 function as DAMP and are recognized by TLR2. Thereafter, TLR2
initiates the inflammatory signaling cascade and induces SASP. 60 It has also been reported that TLR2 is stimulated by lipoteichoic acid (LTA), a component of the cell wall of gram-positive bacteria.
TLR2 stimulation induces expression of SASP factors through the NF-κB signaling pathway to promote development of obesity-associated HCC. 48 In concordance with these findings, HMGB1 was also recognized by TLR4, resulting in increased SASP factor secretion. 59 Taken together, these results indicate that senescent cells secrete pro-inflammatory factors in response to genotoxic stress and this may be associated with pathobiological effects in the cancer microenvironment.
| A NOVEL PATHWAY FOR S ENE SCEN CE-A SSO CIATED S ECRE TORY PHENOT YPE INDUC TION: CG A S-S TING S IG NALING
The 
65-67
The emerging evidence indicates that the cGAS-STING pathway detects self-derived DNA fragments and activates SASP in senescent cells ( Figure 3) . 62, 64 There are several possibilities for the candidate ligands that activate the DNA-sensing machinery underlying cellular senescence. Downregulation of Lamin B1 leads to collapse of the nuclear envelope, which can trigger release of chromatin fragments from the nucleus to the cytosol, termed cytoplasmic chromatin fragments (CCF). 68 DNA damage promotes the production of cytosolic DNA, such as CCF, mtDNA, cDNA, micronuclei and nuclear buds. 69, 70 However, the mechanism of cytosolic DNA accumulation in the cytoplasm of senescent cells has remained unclear. Therefore, we focused on this molecular mechanism. In normal cells, the cytoplasmic DNases, DNase2 and TREX1, degrade the double-stranded and single-stranded DNA in the cytoplasm to prevent activation of the innate immune response. 71, 72 However, downregulation of DNase2 and TREX1, which are transcriptional targets of the E2F complex, results in accumulation of cytosolic DNA, promoting SASP in senescent cells. 73 De Cecco et al 74 reported high transcription levels of the long-interspersed element-1 (LINE-1, also known as L1), a retrotransposable element, in senescent cells. LINE-1 possesses high reverse transcriptase activity, which can transcribe mRNA to cDNA in the cytosol. 75 Therefore, increases in LINE-1 transcription during senescence facilitates accumulation of cDNA in the cytoplasm and triggers cGAS-STING signaling to produce SASP factors.
We propose that senescent cells secrete not only inflammatory proteins but also small extracellular vesicles, such as exosomes. 76, 77 Interestingly, cGAMP is also secreted from cancer cells via SLC19A1, which induces activation of the STING pathway in recipient cells. 78, 79 There is a possibility that senescent cells secrete cGAMP to promote the paracrine innate immune response via SLC19A1.
| THE CG A S-S TING PATHWAY AND C AN CER
Chronic inflammation caused by SASP via the cGAS-STING pathway is crucial for the development of HCC in the obesity-induced liver cancer model. 73 Knocking out the STING gene blunted SASP factor production in HSC and attenuated the development of obesity-associated HCC in the mouse model. 73 
| CON CLUS ION
In this review, we illustrated that SASP factors can induce immunosurveillance and act as a tumor suppression mechanism. Conversely, SASP factors may provoke both tumorigenesis and age-related diseases due to exposure to chronic inflammation. Many researchers have attempted to establish senolytic drugs to eliminate harmful senescent cells from aged tissues, thereby preventing cancer and age-related pathologies. Several senolytic drugs, such as ABT-737, BET inhibitors and dasatinib plus quercetin, can selectively induce cell death in senescent cells and effectively improve some symptoms of age-related disease, including cancer, by attenuating SASP factor production. 81 However, the off-target effects of these senolytic molecules are still unknown. In addition, evaluating the efficiency of senolytic therapies in the living body is an important factor to optimize treatment. Thus, we need to carefully consider the clinical application of senolytic drugs for cancer treatment and prevention of age-related disorders. The cGAS-STING pathway may be an alternative potential therapeutic target to control cancer. 82 Based on the role of the cGAS-STING pathway in facilitating anti-tumor immunity and SASP induction, modulation of its activity would be beneficial for cancer immune therapy and to inhibit cancer development. Finally, to extend healthy lifespans via effective therapeutic strategies, significantly more research is necessary to investigate the molecular mechanisms of SASP regulation.
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